Citadel Advisors LLC 13D and 13G filings for AN2 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:16 pm Sale | 2024-09-30 | 13G | AN2 Therapeutics, Inc. ANTX | Citadel Advisors LLC | 22 0.000% | -1,556,820 (-100.00%) | Filing |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | AN2 Therapeutics, Inc. ANTX | Citadel Advisors LLC | 1,556,842 5.200% | 219,849 (+16.44%) | Filing |
| 2023-02-14 08:26 am Sale | 2022-12-31 | 13G | AN2 Therapeutics, Inc. ANTX | Citadel Advisors LLC | 1,336,993 6.900% | -24 (-0.00%) | Filing |
| 2022-04-08 4:11 pm Purchase | 2022-03-29 | 13G | AN2 Therapeutics, Inc. ANTX | Citadel Advisors LLC | 1,337,017 7.100% | 1,337,017 (New Position) | Filing |